Publications:2
Accepting New Patients
- Mount Sinai Doctors
- Treats Children
- Accepting New Patients
Emily Hertzberg, MD
Pediatrics
About Me
Emily H. Hertzberg, MD, is a clinical hospitalist in the Pediatric Hospital Medicine Program at Mount Sinai Kravis Children's Hospital. Dr. Hertzberg graduated from Vanderbilt University with a degree in developmental psychology. She received her medical degree from the Technion-Israel Institute of Technology where she was the recipient of the MD Thesis award. She went on to complete her pediatric residency and chief residency at Mount Sinai. As part of the global health track, she participated in clinical work and quality improvement research focusing on identification of acute malnutrition in the pediatric population at a rural clinic in Uganda. Dr. Hertzberg was the inaugural Pediatric Hospital Medicine fellow at Mount Sinai where she also received a Masters of Science in Clinical Research in 2020. Her Master’s Thesis studied the national rates of hospitalization and resource utilization in children hospitalized with skin and soft tissue infections.
Language
English
Position
ASSISTANT PROFESSOR | Pediatrics, General Pediatrics
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Beth Israel
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Research Topics
Pediatrics
Education
MD, Technion Israel Institute of Technology
MD, Technion: Israel Institute of Technology
Residency, Pediatrics
Mount Sinai Hospital
Fellowship, Pediatrics
Icahn School of Medicine At Mount Sinai
Certifications
American Board of Pediatrics
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
- 1199 SEIU
- AETNA - Commercial
- Affinity Medicaid-Medicare-Essential Exchange
- Amidacare Medicaid
- CIGNA Healthcare
- Centivo
- EmblemHealth - GHI-PPO
- EmblemHealth - HIP
- EmblemHealth - HIP-Medicaid
- Empire Blue Cross Blue Shield - Commercial/Exchange
- Empire Blue Cross Blue Shield - HealthPlus Medicaid
- Empire Blue Cross Blue Shield - Medicare
- Fidelis Health Care
- HealthFirst Medicaid
- Horizon NJ
- Magnacare-Health Care
- Medicare - NJ
- Medicare - NY
- Metroplus
- Multiplan PHCS
- NJ Medicaid
- NY Medicaid
- Oscar
- Oxford - Freedom and Liberty
- Partners Health Plan
- United Health Care - Commercial
- United Health Care - Empire Plan
- United Health Care - Top Tier
- VNSNY Select Health Medicaid
- WellCare Health Plan
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Increase in Rate of Hospitalizations for Pediatric Intentional Acetaminophen Ingestion at a Single Center During the COVID-19 Pandemic. Rachel E. Moss, Emily H. Hertzberg, Hannibal Person, Guillaume Stoffels, Sheemon Zackai, John Bucuvalas, Jennifer K. Gillen. Clinical Pediatrics
- IFN-γ receptor 2 deficiency initial mimicry of multisystem inflammatory syndrome in children (MIS-C). Haoli Jin, Rachel Moss, James C. Reed, Emily Hertzberg, Mariawy Riollano Cruz, Esra Akkoyun, Michael Tosi, Dusan Bogunovic, Charlotte Cunningham-Rundles. Journal of Allergy and Clinical Immunology: In Practice
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Hertzberg during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- SmarterDx
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.